» Articles » PMID: 31501181

Canadian Guideline for Parkinson Disease

Citing Articles

Retrospective database analysis on the demographics and resource utilization of patients with Parkinson's disease in Quebec, Canada.

Baribeau V, Mohammed S, Awan A, Parison D, Lachaine J Clin Park Relat Disord. 2025; 12:100300.

PMID: 39911313 PMC: 11795128. DOI: 10.1016/j.prdoa.2025.100300.


Alternative Therapies for Non-Motor Symptoms in Parkinson's Disease: A Mini Review.

Liu H, Wang X Neuropsychiatr Dis Treat. 2024; 20:2585-2591.

PMID: 39723118 PMC: 11669284. DOI: 10.2147/NDT.S495092.


Adherence of Clinical Practice Guidelines for Oropharyngeal Dysphagia in Parkinson Disease to Trustworthy Standards: A Systematic Survey.

Gandhi P, Tangamornsuksan W, Couban R, Guyatt G, Steele C, Marras C Dysphagia. 2024; .

PMID: 39305303 DOI: 10.1007/s00455-024-10755-6.


Exercise for People with Parkinson's Disease: Updates and Future Considerations.

McGinley J, Nakayama Y Phys Ther Res. 2024; 27(2):67-75.

PMID: 39257520 PMC: 11382789. DOI: 10.1298/ptr.R0030.


Levodopa Equivalent Daily Dosage: Geographical Variations and Real-Life Modules in Parkinson's Disease.

Kukkle P, Kalia L, Habib A, Jagota P, Ojha R, Kandadai R Mov Disord Clin Pract. 2024; 11(11):1388-1395.

PMID: 39215556 PMC: 11542276. DOI: 10.1002/mdc3.14200.


References
1.
Brouwers M, Kho M, Browman G, Burgers J, Cluzeau F, Feder G . AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182(18):E839-42. PMC: 3001530. DOI: 10.1503/cmaj.090449. View

2.
Postuma R, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R . Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015; 77(5):830-9. PMC: 5769479. DOI: 10.1002/ana.24385. View

3.
Shea B, Reeves B, Wells G, Thuku M, Hamel C, Moran J . AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017; 358:j4008. PMC: 5833365. DOI: 10.1136/bmj.j4008. View

4.
Fox S, Katzenschlager R, Lim S, Ravina B, Seppi K, Coelho M . The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2011; 26 Suppl 3:S2-41. DOI: 10.1002/mds.23829. View

5.
Renoux C, DellAniello S, Khairy P, Marras C, Bugden S, Turin T . Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease. Br J Clin Pharmacol. 2016; 82(2):461-72. PMC: 4972162. DOI: 10.1111/bcp.12964. View